Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5476 AL 5490

Mapping out biomarkers for Alzheimer disease

Breteler MM.

JAMA. 2011 Jan 19;305(3):304-5. doi: 10.1001/jama.2010.2017.

Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1

Mayeux R, Reitz C, Brickman AM, Haan MN, Manly JJ, Glymour MM, Weiss CC, Yaffe K, Middleton L, Hendrie HC, Warren LH, Hayden KM, Welsh-Bohmer KA, Breitner JC, Morris JC.

Alzheimers Dement. 2011 Jan;7(1):15-34. doi: 10.1016/j.jalz.2010.11.005.

Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease

Rahmadi A, Steiner N, Münch G.

Clin Chem Lab Med. 2011 Mar;49(3):385-91. doi: 10.1515/CCLM.2011.079. Epub 2011 Jan 31.

Biomarkers in Alzheimer's disease

Demarin V, Zavoreo I, Kes VB, Simundić AM.

Clin Chem Lab Med. 2011 May;49(5):773-8. doi: 10.1515/CCLM.2011.139. Epub 2011 Feb 9.

Epidemiology of Alzheimer disease

Reitz C, Brayne C, Mayeux R.

Nat Rev Neurol. 2011 Mar;7(3):137-52. doi: 10.1038/nrneurol.2011.2. Epub 2011 Feb 8.

Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease

Prvulovic D, Hampel H.

Clin Chem Lab Med. 2011 Mar;49(3):367-74. doi: 10.1515/CCLM.2011.087. Epub 2011 Feb 23.

Alzheimer's disease

Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E.

Lancet. 2011 Mar 19;377(9770):1019-31. doi: 10.1016/S0140-6736(10)61349-9. Epub 2011 Mar 1.

BACE1 as a potential biomarker for Alzheimer's disease

Decourt B, Sabbagh MN.

J Alzheimers Dis. 2011;24 Suppl 2(Suppl 2):53-9. doi: 10.3233/JAD-2011-110017.

Biomarkers and Alzheimer spectrum

Takeda M.

Psychiatry Clin Neurosci. 2011 Mar;65(2):115-20. doi: 10.1111/j.1440-1819.2011.02197.x.

[Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice]

Koric L, Felician O, Ceccaldi M.

Rev Neurol (Paris). 2011 Jun-Jul;167(6-7):474-84. doi: 10.1016/j.neurol.2010.10.007. Epub 2011 Mar 21.

Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues

Brambilla D, Le Droumaguet B, Nicolas J, Hashemi SH, Wu LP, Moghimi SM, Couvreur P, Andrieux K.

Nanomedicine. 2011 Oct;7(5):521-40. doi: 10.1016/j.nano.2011.03.008. Epub 2011 Apr 6.

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH.

Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21.

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH.

Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH.

Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias